The abstract reports higher stability of p-tau181 to repeated freezing-thaw cycles compared to Aβ species, but provides no mechanistic explanation. Understanding this differential stability could inform biomarker handling protocols and reveal structural properties affecting clinical utility. Gap type: unexplained_observation Source paper: Plasma p-tau181 and amyloid markers in Alzheimer's disease: A comparison between Lumipulse and SIMOA. (2024, Neurobiology of aging, PMID:39208716)
Landscape Summary: Why does p-tau181 show superior freeze-thaw stability compared to amyloid peptides in plasma? is a 0.72 priority gap in biomarker-development. It has 0 linked hypotheses with average composite score 0.000. Status: open.
Colonna, Sevlever, et al. (TREM2 biology)
Why does p-tau181 show superior freeze-thaw stability compared to amyloid peptides in plasma? — INVOKE-2 (completed)
No hypotheses linked to this gap yet.
No knowledge graph edges recorded
No activity recorded yet.
No discussions yet. Be the first to comment.
Create sub-tasks to investigate specific aspects of this gap: